Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Emma Jane Hodge has worked on the following 20 EPO patent applications which have been published in the last five years:

EP11785381

SUBSTITUTED CARBAMOYLCYCLOALKYL ACETIC ACID DERIVATIVES AS NEP INHIBITORS

IPC classification:
A61K 31/192, A61K 31/216, A61K 31/341, A61K 31/40, A61K 31/437, A61K 31/4402, A61P 9/08, C07C 235/36, C07C 235/40, C07D 207/16, C07D 213/55, C07D 235/00, C07D 257/04, C07D 307/52
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11790902

SUBSTITUTED AMINO BISPHENYL PENTANOIC ACID DERIVATIVES AS NEP INHIBITORS

IPC classification:
A61K 31/192, A61K 31/216, A61P 9/08, C07C 235/70
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP12742957

4 - PIPERIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS

IPC classification:
A61K 31/4523, A61K 35/00, C07D 401/04, C07D 401/14, C07D 471/04, C07D 487/04, C07D 491/04, C07D 495/04, C07D 498/04, C07D 513/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12742995

4-OXO-3,5,7,8-TETRAHYDRO-4H-PYRANO {4,3-D} PYRMINIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS

IPC classification:
A61K 31/519, A61P 35/00, C07D 491/052
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12742994

NOVEL 2-PIPERIDIN-1-YL-ACETAMIDE COMPOUNDS FOR USE AS TANKYRASE INHIBITORS

IPC classification:
A61K 31/506, A61K 31/517, A61K 31/519, A61P 35/00, C07D 401/12, C07D 409/14, C07D 491/052
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12772493

BICYCLIC HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

IPC classification:
A61K 31/4162, A61K 31/4188, A61P 9/12, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12783308

HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CYSTIC FIBROSIS

IPC classification:
A61K 31/4439, A61K 31/497, A61P 11/00, C07D 413/04, C07D 417/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12780535

CHOLINE SALT OF AN ANTI - INFLAMMATORY SUBSTITUTED CYCLOBUTENEDIONE COMPOUND

IPC classification:
A61K 31/18, A61P 29/00, C07C 215/40, C07C 311/48
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP12805775

PYRAZOLOPYRROLIDINE COMPOUNDS

IPC classification:
A61K 31/4162, A61K 31/4439, A61K 31/506, A61K 31/513, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12783311

N-SUBSTITUTED HETEROCYCLYL CARBOXAMIDES

IPC classification:
A61K 31/415, A61K 31/4439, A61K 31/497, A61P 11/06
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13707037

SALTS OF AN IP RECEPTOR AGONIST

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13705579

7,8- DIHYDROPYRIDO [3, 4 - B]PYRAZINES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) AND RELATED DISORDERS

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13705578

FUSED PYRROLES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) AND RELATED DISORDERS

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13705581

FUSED DIHYDROPYRIDO [2,3 -B]PYRAZINES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) AND RELATED DISORDERS

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13707437

FUSED PIPERIDINES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PAH AND RELATED DISORDERS

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13705582

FUSED PIPERIDINES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) AND RELATED DISORDERS

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13711952

IMIDAZOPYRROLIDINONE COMPOUNDS

IPC classification:
A61K 31/4188, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP14155848

Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors

IPC classification:
A61K 31/41, A61K 31/415, A61K 31/42, A61P 7/10, C07D 231/40, C07D 257/06, C07D 261/14
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP13720079

CRYSTALLINE FORM OF A SUCCINATE SALT

IPC classification:
A61K 31/438, A61P 11/00, A61P 35/00, C07D 471/10
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11784638

METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY

IPC classification:
A61K 31/192, A61K 31/194, A61K 31/197, A61K 31/198, A61K 31/216, A61K 31/235, A61K 31/265, A61K 31/335, A61K 31/34, A61K 31/35, A61K 31/381, A61K 31/40, A61K 31/41, A61K 31/42, A61K 31/44, A61K 31/505, A61K 31/513, A61K 31/5375, A61K 31/55, A61K 45/06, A61P 13/12
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature